on plasma d-dimer in liver disease and cardiovascular disease in clinical（在等离子体肺动脉栓塞在临床肝脏疾病和心血管疾病）.docVIP

On plasma D-dimer in liver disease and cardiovascular disease in clinical [Abstract] Objective To investigate the D_ dimer (D-dinner the relationship between change and disease. Methods CA-1500 automatic blood coagulation detected four diseases and their treatment before and after in D_ dimer plasma levels of change The results of chronic hepatitis (moderate and severe cirrhosis of plasma D_ dimer levels higher than the control group, ie P lt;0.05, but chronic hepatitis (mild increase was not obvious (Pgt; 0.05, and different clinical hepatitis dimer levels between patients D_ significant difference (P lt;0.05, with hepatitis disease increase, D_ dimer has also been increasing while acute myocardial infarction and brain trauma patients plasma D_ dimer levels are higher than the control group (P lt;0.05, P lt;0.01. Conclusion D_ dimer can not only reflect the different degrees of fibrinolysis in patients with hyperthyroidism, and is a primary fibrinolysis and identification secondary fibrinolysis and monitoring valuable indicators of thrombolytic therapy, but also as hepatitis severity and prognosis of the indicators, their role in a major. [Keywords] D_ liver dimer clinical cardiovascular disease D_ dimer (D-Diner, DD) is a cross-linked fibrin (Fb-specific degradation products, which reflects the generation and increased activation of coagulation and fibrinolytic system is a primary fibrinolysis and continue to identify onset of fibrinolysis and monitoring indicators of benefit of thrombolytic therapy in the past 10 years, has established a variety of valuable DD detection methods. a large number of studies have fully confirmed the DD in liver disease and cardiovascular disease in the application of value, this of normal and four patients D_ dimer, and in these types of diseases specifically addressed the clinical effects, and detailed as follows. A Materials and Methods (A source Using the CA-1500 from the full-motion blood coagulation analyz